-
Revenue
$-20.70M
Net Income
-
Gross Margin
-
Op. Margin
$-26.38M
Free Cash Flow
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
Q1 2024 (Mar 31, 2024) |
Q2 2023 (Jun 30, 2023) |
Q1 2023 (Mar 31, 2023) |
Q4 2022 (Dec 31, 2023) |
Q3 2022 (Sep 30, 2022) |
Q2 2022 (Jun 30, 2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses | $7.03M | $4.95M | $4.01M | $3.51M | $5.81M | $3.14M | $2.96M | - | - | - | - | - |
| Research & Development | $1.53M | $1.86M | $1.31M | $132.00K | $3.09M | $25.00K | $128.00K | - | - | - | - | - |
| Operating Income | $-7.03M | $-4.95M | $-4.01M | $-3.51M | $-5.81M | $-3.14M | $-2.96M | $-406.27K | $-507.41K | $-4.47M | $-246.36K | $-279.42K |
| Interest Expense | - | - | $170.00K | - | $80.00K | $80.00K | $80.00K | - | - | - | - | - |
| Interest Income | - | - | - | - | - | $2.00K | $9.00K | $275.29K | $664.23K | $-796.69K | $609.92K | $191.59K |
| Other Income/Expense | $-44.00K | $-1.02M | $-969.00K | $2.06M | $-341.00K | $-2.13M | $-487.00K | $275.29K | $664.23K | $4.11M | $609.92K | $191.59K |
| Income Before Tax | - | - | - | - | - | - | - | $-130.98K | $156.83K | - | $363.56K | $-87.83K |
| Income Tax Expense | - | - | - | - | - | - | - | $212.74K | $36.56K | - | $156.65K | $29.70K |
| Net Income | $-7.12M | $-6.03M | $-5.15M | $-2.41M | $-6.46M | $-5.38M | $-3.55M | $-343.71K | $120.27K | $-370.83K | $206.91K | $-117.54K |
| Basic EPS | -13.16 | -5.46 | -1.32 | -20.33 | -0.07 | -0.07 | -0.05 | nan | nan | nan | nan | nan |
| Diluted EPS | -13.16 | -5.46 | -1.32 | -20.33 | -0.07 | -0.07 | -0.05 | nan | nan | nan | nan | nan |
| Basic Shares Outstanding | 541K | 1.1M | 3.9M | -77.4M | 87.2M | 73.9M | 73.8M | - | - | - | - | - |
| Diluted Shares Outstanding | 541K | 1.1M | 3.9M | -77.4M | 87.2M | 73.9M | 73.8M | - | - | - | - | - |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
Q1 2024 (Mar 31, 2024) |
Q2 2023 (Jun 30, 2023) |
Q1 2023 (Mar 31, 2023) |
Q4 2022 (Dec 31, 2023) |
Q3 2022 (Sep 30, 2022) |
Q2 2022 (Jun 30, 2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.84M | $3.33M | $2.13M | $554.00K | $71.00K | $219.00K | $1.84M | $277.76K | $90.61K | $4.23M | $728.07K | $837.69K |
| Other Current Assets | $1.19M | $1.29M | $1.73M | $2.16M | $1.25M | $1.17M | $1.31M | - | - | $1.50M | - | - |
| Total Current Assets | $7.09M | $6.39M | $5.95M | $2.71M | $1.40M | $1.60M | $3.16M | $354.49K | $310.02K | $5.73M | $1.15M | $1.33M |
| Property Plant & Equipment | $325.00K | $381.00K | $41.00K | $40.00K | $48.00K | $50.00K | - | - | - | - | - | - |
| Total Assets | $8.55M | $7.99M | $7.32M | $4.19M | $2.99M | $3.31M | $4.92M | $23.69M | $23.97M | $7.22M | $136.85M | $136.47M |
| Accounts Payable | $613.00K | $1.25M | $714.00K | $1.43M | $1.90M | $1.06M | $117.00K | - | - | $215.00K | - | - |
| Accrued Liabilities | - | - | - | - | - | - | - | $24.53K | $1.43M | - | $316.13K | $138.65K |
| Total Current Liabilities | $4.26M | $4.41M | $4.55M | $10.74M | $11.98M | $2.86M | $1.98M | $2.03M | $1.96M | $1.80M | $316.13K | $138.65K |
| Total Liabilities | $4.27M | $4.46M | $4.63M | $10.99M | $12.11M | $8.77M | $8.02M | $6.66M | $6.59M | $7.68M | $4.94M | $4.77M |
| Common Stock | - | - | $19.00K | $14.00K | $10.00K | $7.00K | $7.00K | - | - | $7.00K | - | - |
| Retained Earnings | $-47.00M | $-39.88M | $-34.25M | $-29.10M | $-26.70M | $-20.23M | $-14.85M | $-6.07M | $-5.48M | $-11.30M | $-3.70M | $-3.30M |
| Total Stockholders Equity | $4.28M | $3.53M | $2.69M | $-6.79M | $-9.12M | $-5.46M | $-3.10M | $-6.07M | $-5.48M | $-457.00K | $-3.70M | $-3.30M |
| Total Liabilities & Equity | $8.55M | $7.99M | $7.32M | $4.19M | $2.99M | $3.31M | $4.92M | $23.69M | $23.97M | $7.22M | $136.85M | $136.47M |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
Q1 2024 (Mar 31, 2024) |
Q2 2023 (Jun 30, 2023) |
Q1 2023 (Mar 31, 2023) |
Q4 2022 (Dec 31, 2023) |
Q3 2022 (Sep 30, 2022) |
Q2 2022 (Jun 30, 2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-7.12M | $-10.78M | $-5.15M | $-2.41M | $-6.46M | $-5.38M | $-3.55M | $-223.44K | $120.27K | $-370.83K | $206.91K | $-117.54K |
| Stock-based Compensation | $1.97M | $394.00K | $234.00K | $362.00K | $1.27M | $914.00K | $431.00K | - | - | - | - | - |
| Change in Payables | $-840.00K | $-236.00K | $-721.00K | $-419.00K | $1.64M | - | - | - | - | - | - | - |
| Operating Cash Flow | $-10.92M | $-6.51M | $-4.33M | $-3.81M | $-5.87M | $-3.87M | $-2.36M | $-1.22M | $-599.82K | $-6.80M | $-929.01K | $-819.40K |
| Capital Expenditure | $398.00K | $405.00K | $4.00K | - | $51.00K | $10.00K | - | - | - | - | - | - |
| Purchases of Investments | - | - | - | - | - | - | - | - | - | - | $134.90M | $134.90M |
| Investing Cash Flow | $-1.40M | $-405.00K | $-4.00K | $85.00K | $-128.00K | $-224.00K | - | $114.47M | $113.88M | $135.62M | $-134.90M | $-134.90M |
| Stock Issued | $17.96M | $11.95M | $8.06M | - | - | - | - | - | - | - | - | - |
| Stock Repurchased | - | - | - | - | - | - | - | $114.07M | $113.83M | - | - | - |
| Financing Cash Flow | $15.68M | $9.68M | $5.93M | $4.21M | $1.86M | $113.00K | - | $-113.32M | $-113.53M | $-125.57M | $136.50M | $136.50M |
| Net Change in Cash | $3.28M | $2.78M | $1.58M | $483.00K | $-4.16M | $-4.01M | $-2.38M | $-68.02K | $-255.17K | $3.55M | $679.52K | $789.13K |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Operating Expenses | $7.03M | $5.81M | $15.60M | $11.91M |
| Research & Development | $1.53M | $3.09M | $4.31M | $3.25M |
| Operating Income | $-7.03M | $-5.81M | $-15.60M | $-11.91M |
| Interest Expense | - | - | - | $80.00K |
| Other Income/Expense | $-44.00K | $-341.00K | $-2.04M | $-2.95M |
| Net Income | $-7.12M | $-6.46M | $-17.90M | $-15.40M |
| Basic EPS | -13.16 | -889.58 | -74.92 | -2359.18 |
| Diluted EPS | -13.16 | -889.58 | -74.92 | -2359.18 |
| Basic Shares Outstanding | $540.84K | $7.26K | $238.92K | $6.53K |
| Diluted Shares Outstanding | $540.84K | $7.26K | $238.92K | $6.53K |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $3.84M | $554.00K |
| Other Current Assets | $1.19M | $1.78M |
| Total Current Assets | $7.09M | $2.71M |
| Property Plant & Equipment | $325.00K | $40.00K |
| Total Assets | $8.55M | $4.19M |
| Accounts Payable | $613.00K | $1.43M |
| Total Current Liabilities | $4.26M | $10.74M |
| Total Liabilities | $4.27M | $10.99M |
| Common Stock | - | - |
| Retained Earnings | $-47.00M | $-29.10M |
| Total Stockholders Equity | $4.28M | $-6.79M |
| Total Liabilities & Equity | $8.55M | $4.19M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-7.12M | $-6.46M | $-17.90M | $-15.40M |
| Stock-based Compensation | - | - | $1.97M | $1.27M |
| Change in Payables | - | - | $-840.00K | $1.64M |
| Operating Cash Flow | - | - | $-10.92M | $-5.87M |
| Capital Expenditure | - | - | $398.00K | $51.00K |
| Investing Cash Flow | - | - | $-1.40M | $-128.00K |
| Stock Issued | - | - | $17.96M | - |
| Financing Cash Flow | - | - | $15.68M | $1.86M |
| Net Change in Cash | - | - | $3.28M | $-4.16M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.